Latest muscular dystrophy Stories
SOUTH PLAINFIELD, N.J., March 3, 2015 /PRNewswire/ -- PTC Therapeutics, Inc.
MDA research grantee Charles Gersbach announces potentially game-changing advance in gene modification for boys and young men with DMD. Chicago, IL (PRWEB) February
-Translarna(TM) approved in the European Union and recently launched in Germany- SOUTH PLAINFIELD, N.J., Feb. 27, 2015 /PRNewswire/ -- PTC Therapeutics, Inc.
- Small Steps Fund Powerful Progress - CHICAGO, Feb.
Leading Duchenne organizations partner to enable long-term trials of novel anti-inflammatory drug; chronic toxicology studies will pave regulatory path to Phase 2a studies later this year
PPMD's Annual Advocacy Conference Focused on Implementing MD-CARE Act Amendments & Strengthening Patient Voice at FDA WASHINGTON, Feb.
Product holds potential for replacing glucocorticoids in Duchenne muscular dystrophy and other chronic inflammatory states SILVER SPRING, Md. and CHICAGO, Feb.
SAN DIEGO, Feb. 18, 2015 /PRNewswire/ -- aTyr Pharma, Inc.
#MDAshamrocks CHICAGO, Feb.
HACKENSACK, N.J., Feb.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.